The Relationship between Expression of the Sodium/iodide Symporter Gene and the Status of Hormonal Receptors in Human Breast Cancer Tissue
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: It has been reported that the sodium/iodide symporter (NIS) gene is expressed in several breast cancer tissues, suggesting the possibility of radionuclide imaging and therapy. However, the regulatory mechanism of NIS gene expression in breast cancer is not yet understood. To assess the relationship between the hormonal status and the NIS expression in breast cancer tissue, we investigated the NIS expression and correlated it to the expression of the thyrotropin receptor (thyroid stimulating hormone receptor, TSH-R), the estrogen receptor (ER) and the progesterone receptor (PR) in human breast cancer tissues. Materials and Methods: Breast cancer tissues were obtained from 44 patients. Pathological examination showed 2 cases of Grade I, 17 of Grade II, 22 of Grade III, and 3 of unknown grade. We measured the expression of NIS and TSH-R genes by using RT-PCR and we measured the status of ER and PR by using immunohistochemistry. Results: The NIS gene was expressed in 15 (34%) of the 44 breast cancer tissues. The NIS gene was expressed in 32% of the cases with TSH-R gene expression. The NIS gene was expressed in 40% of the breast cancer tissues with a positive PR and in 31% with a negative PR (p＞0.05). It was positive for PR in 18% of the cases and negative for PR in 39% of the cases (p＞0.05). Conclusion: The NIS gene is expressed in approximately one-third of the human breast cancer tissues. Its expression was not related to the presence of the TSH-R gene or hormonal receptors, ER and PR.
Abstract
Purpose: It has been reported that the sodium/iodide symporter (NIS) gene is expressed in several breast cancer tissues, suggesting the possibility of radionuclide imaging and therapy. However, the regulatory mechanism of NIS gene expression in breast cancer is not yet understood. To assess the relationship between the hormonal status and the NIS expression in breast cancer tissue, we investigated the NIS expression and correlated it to the expression of the thyrotropin receptor (thyroid stimulating hormone receptor, TSH-R), the estrogen receptor (ER) and the progesterone receptor (PR) in human breast cancer tissues. Materials and Methods: Breast cancer tissues were obtained from 44 patients. Pathological examination showed 2 cases of Grade I, 17 of Grade II, 22 of Grade III, and 3 of unknown grade. We measured the expression of NIS and TSH-R genes by using RT-PCR and we measured the status of ER and PR by using immunohistochemistry. Results: The NIS gene was expressed in 15 (34%) of the 44 breast cancer tissues. The NIS gene was expressed in 32% of the cases with TSH-R gene expression. The NIS gene was expressed in 40% of the breast cancer tissues with a positive PR and in 31% with a negative PR (p＞0.05). It was positive for PR in 18% of the cases and negative for PR in 39% of the cases (p＞0.05). Conclusion: The NIS gene is expressed in approximately one-third of the human breast cancer tissues. Its expression was not related to the presence of the TSH-R gene or hormonal receptors, ER and PR.
참고문헌 (20)
- "Sodium iodide symporter: its role in nuclear medi-cine", 43, pp.1188~200 (2002)
- "The sodium", iodide Symporter (NIS) characterization, regulation, and medical significance., 2003, pp.24, 48~77
- "Sodium", iodide symporter:a key transport system in thyroid cancer cell metabolism, 1999, pp.141, 443~57
- "Cloning of the human sodium lodide symporter", 226, pp.339~45 (1996)
- "The mamary gland iodide transporter is expressed during lactation and in breast cancer", 6, pp.871~8 (2000)
- "Nuclear medicine and breast cancer: a review of current strategies and novel therapies.", 10, pp.184~97 (2001)
- "Correlation between 99mTc-pertechnetate uptakes and ex-pressions of human sodium iodide symporter gene in breast tumor tissues", 28, pp.829~34 (2001)
- "Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.", 77, pp.157~65 (2003)
- "Tissue iodine content and serum- mediated 125I uptake-blocking activity in breast cancer", 85, pp.1245~50 (2000)
- "Regulation by thyroid-stimulating hormone of sodium", iodide symporter gene expression and protein levels in FRTL-5 cells, 1997, pp.138, 2227~32
- "Estradiol increases proliferation and down-regulates the sodium", iodide symporter gene in FRTL-5 cells, 1999, pp.140, 5705~11
- "Imunohistochemical profile of the sodium", iodide symporter in thyroid,breast,and other car-cinomas using high density tissue microarrays and conven-tional sections, 2003, pp.88, 1880~8
- "Effect of prolactin on sodium iodide symporter expression in mouse mammary gland ex-plants", 279, pp.769~72 (2000)
- "Hormonal regulation of radioiodide uptake activity and Na+", I- symporter expression in mammary glands, 2000, pp.85, 2936~43
- "Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma", 30, pp.1371~7 (2003)
- "Role of the thyroid-stimula-ting hormone receptor signaling in development and differen-tiation of the thyroid gland", 99, pp.15462~7 (2002)
- "A direct relationship betwen thyroid en-largement and breast cancer", 81, pp.937~41 (1996)
- "Relationship between breast cancer and thyroid disease:relevance of autoimmune thyroid disorders inbreast malignancy", 81, pp.990~4 (1996)
- "Serum thyroid peroxidase autoantibodies,thyroid volume,and outcome in breast carcinoma", 83, pp.2711~6 (1998)
- "Rhenium-188 as an alternative to Iodine-131 for treatment ofbreast tumors expressing the sodium", iodide symporter (NIS)., 2002, pp.29, 13~8